Open AccessEffect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer
Author(s) -
Xiaohong Fan,
Qingyu Xiu
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.159085
Subject(s) - xrcc1 , medicine , odds ratio , chemotherapy , meta analysis , confidence interval , oncology , lung cancer , biology , genetics , gene , genotype , single nucleotide polymorphism
X-ray repair cross complementing group 1 (XRCC1) has been indicated to be correlated with the efficacy of platinum-based chemotherapy. But study results were still debatable. Thus, a meta-analysis was conducted.